Total Payments
$2,472
2023 Payments
$746.58
Companies
22
Transactions
151
Medicare Patients
794
Medicare Billing
$85,077
Payment Breakdown by Category
Food & Beverage$2,457 (99.4%)
Education$14.80 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,457 | 150 | 99.4% |
| Education | $14.80 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $552.70 | 21 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $416.21 | 29 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $297.75 | 22 | $0 (2023) |
| Celgene Corporation | $236.75 | 17 | $0 (2023) |
| QOL Medical, LLC | $144.38 | 13 | $0 (2019) |
| INTERCEPT PHARMACEUTICALS, INC. | $102.70 | 5 | $0 (2023) |
| Allergan Inc. | $102.06 | 7 | $0 (2019) |
| PFIZER INC. | $72.53 | 5 | $0 (2023) |
| Janssen Biotech, Inc. | $68.10 | 5 | $0 (2023) |
| NESTLE HEALTHCARE NUTRITION INC. | $66.68 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $746.58 | 37 | ABBVIE INC. ($170.72) |
| 2022 | $487.46 | 24 | ABBVIE INC. ($216.57) |
| 2021 | $447.53 | 33 | Takeda Pharmaceuticals U.S.A., Inc. ($181.47) |
| 2020 | $168.65 | 10 | AbbVie Inc. ($67.31) |
| 2019 | $184.08 | 13 | UCB, Inc. ($39.02) |
| 2018 | $177.70 | 15 | Takeda Pharmaceuticals U.S.A., Inc. ($69.11) |
| 2017 | $260.08 | 19 | QOL Medical, LLC ($99.96) |
All Payment Transactions
151 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/16/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/15/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Gastroenterology | ||||||
| 10/30/2023 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/26/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $9.05 | General |
| Category: Neuroscience | ||||||
| 09/18/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $17.81 | General |
| Category: Neuroscience | ||||||
| 09/18/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $8.17 | General |
| Category: Neuroscience | ||||||
| 09/06/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: Gastroenterology | ||||||
| 09/05/2023 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 08/31/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $15.70 | General |
| Category: Neuroscience | ||||||
| 08/28/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: Gastroenterology | ||||||
| 08/24/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $25.79 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/23/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: Gastroenterology | ||||||
| 08/23/2023 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: IMMUNOLOGY | ||||||
| 08/22/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $124.68 | General |
| Category: IMMUNOLOGY | ||||||
| 08/21/2023 | NESTLE HEALTHCARE NUTRITION INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: GI | ||||||
| 08/10/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: Immunology | ||||||
| 08/03/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $18.49 | General |
| Category: Neuroscience | ||||||
| 07/19/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Gastroenterology | ||||||
| 07/19/2023 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $12.13 | General |
| Category: IMMUNOLOGY | ||||||
| 07/11/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $20.12 | General |
| Category: Neuroscience | ||||||
| 07/06/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $9.08 | General |
| Category: Neuroscience | ||||||
| 06/28/2023 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $30.36 | General |
| Category: GI | ||||||
| 06/15/2023 | INTERCEPT PHARMACEUTICALS, INC. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 06/01/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $19.26 | General |
| Category: Neuroscience | ||||||
| 05/23/2023 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 128 | 165 | $40,395 | $14,126 |
| 2022 | 9 | 226 | 252 | $78,368 | $24,332 |
| 2021 | 8 | 234 | 291 | $78,551 | $25,226 |
| 2020 | 5 | 206 | 293 | $82,767 | $21,394 |
Total Patients
794
Total Services
1,001
Medicare Billing
$85,077
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 47 | 62 | $15,106 | $5,341 | 35.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 55 | 77 | $13,358 | $4,687 | 35.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 12 | 12 | $6,199 | $2,266 | 36.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 14 | 14 | $5,732 | $1,832 | 32.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 55 | 66 | $13,860 | $5,129 | 37.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 39 | 48 | $13,152 | $5,019 | 38.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 17 | 17 | $11,356 | $3,039 | 26.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 39 | 45 | $6,840 | $2,728 | 39.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 19 | 19 | $5,776 | $2,310 | 40.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 14 | 14 | $5,306 | $2,156 | 40.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 13 | 13 | $8,684 | $1,639 | 18.9% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 13 | 13 | $5,200 | $1,197 | 23.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 17 | 17 | $8,194 | $1,115 | 13.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 78 | 126 | $19,084 | $7,214 | 37.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 28 | 32 | $8,768 | $4,334 | 49.4% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 20 | 20 | $13,360 | $3,507 | 26.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 38 | 41 | $8,560 | $3,260 | 38.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 24 | 24 | $7,258 | $2,458 | 33.9% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 18 | 18 | $12,024 | $2,233 | 18.6% |
| 45378 | Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk | Facility | 2021 | 13 | 13 | $8,632 | $1,795 | 20.8% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2021 | 15 | 17 | $865.00 | $424.15 | 49.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 97 | 183 | $24,705 | $8,556 | 34.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope | Facility | 2020 | 26 | 26 | $17,368 | $4,650 | 26.8% |
| 45380 | Biopsy of large bowel using an endoscope | Facility | 2020 | 34 | 35 | $23,380 | $3,431 | 14.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 32 | 32 | $9,120 | $3,171 | 34.8% |
About Dr. Ted Rea, M.D
Dr. Ted Rea, M.D is a Gastroenterology healthcare provider based in Twin Falls, Idaho. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497795215.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ted Rea, M.D has received a total of $2,472 in payments from pharmaceutical and medical device companies, with $746.58 received in 2023. These payments were reported across 151 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($2,457).
As a Medicare-enrolled provider, Rea has provided services to 794 Medicare beneficiaries, totaling 1,001 services with total Medicare billing of $85,077. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Twin Falls, ID
- Active Since 06/08/2006
- Last Updated 12/27/2017
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1497795215
Products in Payments
- XIFAXAN (Drug) $263.19
- ZEPOSIA (Drug) $228.12
- ENTYVIO (Biological) $204.78
- SKYRIZI (Biological) $169.83
- RINVOQ (Biological) $166.79
- Sucraid (Drug) $144.38
- HUMIRA (Biological) $131.39
- OCALIVA (Drug) $102.70
- MOTEGRITY (Drug) $88.13
- Entyvio (Biological) $80.98
- XELJANZ (Drug) $72.53
- LINZESS (Drug) $68.79
- VOWST (Biological) $63.62
- DIFICID (Drug) $56.86
- STELARA (Biological) $52.42
- ZENPEP (Drug) $46.19
- INJECTAFER (Drug) $44.90
- Cimzia (Drug) $39.02
- GATTEX (Drug) $38.84
- MAVYRET (Drug) $33.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Twin Falls
Dr. Michael Weaver, Md, MD
Gastroenterology — Payments: $37,101
Gastroenterology $37,101
Judith Csanky, Md, MD
Gastroenterology — Payments: $3,441
Gastroenterology $3,441
Seth Wheeler, Md, MD
Gastroenterology — Payments: $2,979
Gastroenterology $2,979
Robert Ward, M.d, M.D
Gastroenterology — Payments: $1,106
Gastroenterology $1,106
Dr. Imad Jaafar, Md, MD
Gastroenterology — Payments: $108.21
Gastroenterology $108.21